✨ Free AI Report
PureTech Health plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research PureTech Health plc
Company Research

PureTech Health plc: Business Overview, Financials & Competitive Analysis

PureTech Health is a hub-and-spoke biotherapeutics company developing and commercializing biotechnology and pharmaceutical solutions through a proven, capital-efficient R&D model focused on opportunities with validate...

Analyst-debate audio for PureTech Health plc

AskCyborg analysts argue the bull and bear cases for PureTech Health plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Clinical-stage biotech with FDA-approved assets and promising pipeline candidates in oncology and psychiatry, supported by...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals & Clinical-Stage Biotech
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest PureTech Health plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

PureTech Health plc Overview

Pro stress-test →

PureTech Health is a hub-and-spoke biotherapeutics company developing and commercializing biotechnology and pharmaceutical solutions through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. The company has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval.

Strategic Profile

Pro stress-test →

The company focuses on developing medicines for diseases based on insights into the biology and connectivity of the brain, immune, and gut systems. By identifying, shaping, and de-risking high-conviction assets and scaling them through dedicated structures backed by external capital, PureTech accelerates their path to patients while creating sustainable value for shareholders.

Competitive Landscape

Pro stress-test →

PureTech develops medicines based on insights into the brain, immune, and gut systems. Direct competitors include Lygenesis (cellular engineering), Pulmatrix (inhalation therapeutics), and larger pharma companies focused on IPF (Roche, Boehringer Ingelheim) and oncology (Roche, Merck). PureTech's competitive advantages include its de-risked pipeline, FDA approvals, and capital-efficient structure.

Industry Context

PureTech Health plc operates in Biopharmaceuticals & Clinical-Stage Biotech.

Key facts

Founded: 2015 · Headquarters: Boston, Massachusetts

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on PureTech Health plc.

  • Hub-and-spoke model reduces corporate overhead while preserving upside through Founded Entities—Celea and Gallop expected to transition operational costs off balance sheet in 2026
  • LYT-200 (Gallop Oncology) showing durable clinical responses in relapsed/refractory AML with favorable tolerability profile; FDA Fast Track and Orphan Drug designations granted
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025Gallop Oncology announces positive Phase 1b data for LYT-200 in AML with 38% complete response and 13.2-month median overall survival
  • August 2025Launch of Celea Therapeutics as Founded Entity to advance deupirfenidone (LYT-100) toward Phase 3 IPF trial
  • +1 moreTrack every material event for PureTech Health plc as it happens. Explore monitoring →
Get alerted when PureTech Health plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pirfenidone/NintedanibStandard-of-care IPF treatments→Anti-galectin-9 monoclonal antibodiesCompetitive oncology immunotherapy space→KarXT (ulotaront)Schizophrenia treatment (PureTech founded entity)→

Compare PureTech Health plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

PureTech Health plc operates in Biopharmaceuticals & Clinical-Stage Biotech. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals & Clinical-Stage Biotech research →
NEW · MCP server

Ask your AI assistant about PureTech Health plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare PureTech Health plc and its top competitor on Cyborg Score”
“What did PureTech Health plc do this quarter?”
“Is PureTech Health plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does PureTech Health plc do?+
PureTech Health is a hub-and-spoke biotherapeutics company developing and commercializing biotechnology and pharmaceutical solutions through a proven, capital-efficient R&D model focused on opportunities with validate...
What is PureTech Health plc's Cyborg Score?+
PureTech Health plc has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are PureTech Health plc's main competitors?+
Named competitors include Pirfenidone/Nintedanib, Anti-galectin-9 monoclonal antibodies, KarXT (ulotaront). The full competitive landscape is in the AskCyborg report.
How can I get the full PureTech Health plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the PureTech Health plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track PureTech Health plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.